Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Giannasi

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Minerva Cardioangiologica|May 1, 1995
[Fibrinogen as a cardiovascular risk factor]G Giannasi, S Ferrari, F Galetta
Minerva Medica|July 1, 1995
[Effects of simvastatin on blood levels of lipoprotein (a)]F Galetta, T Sampietro, G Basta, et al.
Acta Neurologica Scandinavica|April 7, 2018
Why we prefer levetiracetam over phenytoin for treatment of status epilepticusG Zaccara, F S Giorgi, A Amantini, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Minerva Cardioangiologica|May 1, 1995
[Fibrinogen as a cardiovascular risk factor]G Giannasi, S Ferrari, F Galetta
Minerva Medica|July 1, 1995
[Effects of simvastatin on blood levels of lipoprotein (a)]F Galetta, T Sampietro, G Basta, et al.
Acta Neurologica Scandinavica|April 7, 2018
Why we prefer levetiracetam over phenytoin for treatment of status epilepticusG Zaccara, F S Giorgi, A Amantini, et al.
Pageof 1